McGowan warns that comparing the lipolytic effects of each medication based on the results of different studies can cause validity issues due to differing patient populations
Availability of data and materials Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study
When patients are prescribed semaglutide treatments by their licensed healthcare professional or a telehealth provider, they are entitled to receive authentic, FDA-approved and regulated Wegovy," Dave Moore, Novo Nordisk's executive vice president of U.S
What happens if you have an adverse reaction
Many patients with type 2 diabetes or weight management goals ask whether they need both drugs, and the answer depends on individual metabolic factors, blood sugar patterns, and treatment response
Retatrutide, a novel peptide currently being investigated for its potential in metabolic and weight-related studies, is no exception
